Unlock instant, AI-driven research and patent intelligence for your innovation.

High-density fermentation method of recombinant human thymalfasin

A new technology of high-density fermentation and thymus method, which is applied in the new high-density and high-expression fermentation field of recombinant human thymus method, can solve the problem that the yield cannot meet the scale requirements, fermentation scale, cell concentration and fusion protein expression Problems such as not being able to present simultaneously at a high level, low cell concentration and fusion protein expression, to achieve the effect of strong practicability and efficiency

Inactive Publication Date: 2016-08-24
BEIJING NORTHLAND BIOTECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In conclusion, in the current report on the new fermentation process of the recombinant human thymus method, the fermentation scale involved is still in the small-scale research stage below 9L, and although a relatively high cell concentration and fusion protein expression can be obtained in a small-scale fermentation amount, but lower cell concentration and fusion protein expression were obtained during large-scale fermentation. Therefore, the major problem in the reported fermentation process is that the fermentation scale, cell concentration and fusion protein expression cannot be combined. Higher levels appear at the same time, resulting in the production rate not meeting the scale requirements

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • High-density fermentation method of recombinant human thymalfasin
  • High-density fermentation method of recombinant human thymalfasin
  • High-density fermentation method of recombinant human thymalfasin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] 1.30L fermenter pilot high-density fermentation:

[0035] 1) Working seed culture

[0036]Take a strain from the working seed bank at -80°C. After it is completely melted, take 100 μL of the bacterial solution and inoculate it in the primary seed medium (50 mL in a 250 mL Erlenmeyer bottle, containing 50 μg / mL kanamycin), and place in a shaker. The bed was cultivated, the temperature was controlled at 37°C, the rotating speed was 230rpm, and cultured for 8h to obtain the primary seed solution; the primary seed solution was inoculated into the secondary seed medium (800mL in 2L Erlenmeyer flasks containing 50μg / mL kanamycin), placed on a shaker for cultivation, controlled temperature at 37°C, rotation speed at 230rpm, and cultivated for 15-17h to obtain fermentation working seed liquid.

[0037] 2) Inoculate in a 30L fermenter for fermentation

[0038] Inoculate the prepared fermented working seed solution with 10% inoculum in a 30L fermenter containing 14L fermentati...

Embodiment 2

[0070] 1. 100L fermenter pilot high-density fermentation:

[0071] 1) Working seed culture

[0072] Take a strain from the working seed bank at -80°C. After it is completely melted, take 200 μL of the bacterial solution and inoculate it into the primary seed medium (100 mL in a 500 mL Erlenmeyer bottle, containing 50 μg / mL kanamycin), and place in a shaker. The bed is cultivated, the temperature is controlled at 37°C, the rotating speed is 230rpm, and it is cultivated for 8 hours to obtain the first-level seed solution; the first-level seed solution is inoculated on the second-level seed medium with an inoculation amount of 3% (4 2L Erlenmeyer flasks are respectively filled with 800mL, containing 50 μg / mL kanamycin), placed in a shaker for cultivation, controlled temperature at 37° C., rotation speed at 230 rpm, and cultivated for 15-17 hours to obtain fermentation working seed liquid.

[0073] 2) Inoculate in a 100L fermenter for fermentation

[0074] Inoculate the prepared...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of bio-pharmaceuticals, and in particular provides a high-density fermentation method of recombinant human thymalfasin. The high-density fermentation method of the recombinant human thymalfasin disclosed by the invention comprises the following steps: 1) cultivating work seeds; 2) inoculating the work seeds in a fermentation tank for fermenting; 3) supplementing materials before inducing; and 4) inducing expression. With the fermentation method, the efficient expression of the recombinant human thymalfasin in fermentation at a 55L scale is achieved; a final bacterium concentration OD600 can reach 90 or above, and the expression quantity of fusion protein is 45% or above of total protein of bacteria, so that the scale of a recombinant human thymalfasin fermentation process reaches a world's advanced level and the technical problems that the expression quantity of the recombinant human thymalfasin is low and the yield of the recombinant human thymalfasin fails to achieve a large-scale requirement; therefore, a solid foundation is laid for the industrialization of the recombinant human thymalfasin.

Description

(1) Technical field [0001] The invention relates to the technical field of biopharmaceuticals, in particular to a new high-density, high-expression fermentation method of recombinant human thymus. (2) Background technology [0002] Thymus fasin is a small molecular polypeptide with strong immune function secreted by the thymus, consisting of 28 amino acids. In vivo and in vitro tests, thymofasin has effects on the secretion of cytokines, lymphocyte surface markers and lymphocyte function, and plays an important role in the process of the body's immune response. It is considered as a biological response regulator, so it is Widely used as vaccine immune response enhancer for immunocompromised patients, treatment of chronic hepatitis B, hepatitis C, cancer and autoimmune diseases. [0003] There are two methods for the new preparation of thymus: chemical synthesis and genetic engineering. Chemically synthesized thymus faxin: It was developed in the early 1990s by SciSun Pharm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12P21/02C12R1/19
Inventor 聂李亚许松山马素永梁明征
Owner BEIJING NORTHLAND BIOTECH